Tags : Expanding

Pharma Regulatory

MHLW Approves Novartis’ Five New Therapies Expanding its Footprints in

Shots: The five therapies include Tabrecta (capmatinib) for advanced and recurrent unresectable NSCLC, Entresto (sacubitril valsartan sodium hydrate) for chronic HF, Mayzent (siponimod fumaric acid) for secondary PMS, Enerzair (glycopyrronium bromide, indacaterol acetate, mometasone furoate) and Atectura (indacaterol acetate, mometasone furoate) for different forms of asthma In 2020, Novartis has received seven approval in Japan […]Read More


Allergan to Launch Three REFRESH RELIEVA Lubricant Eye Drops Expanding

Shots: Allergan launches three new OTC REFRESH RELIEVA products: REFRESH RELIEVA, REFRESH RELIEVA PF multidose and REFRESH RELIEVA for contacts to relieve discomfort due to eye dryness and to prevent irritation The launch of three unique options to treat patients with dry, irritated eyes and contact lens dryness expands Allergan’s artificial tear, REFRESH portfolio. REFRESH […]Read More